English
简体中文
Total: £ 56.28
Published Date: 2025-06-24 | Pages: 156 | Tables: 141 | Pharma & Healthcare
In 2024, the global market size of Diagnostic Radiopharmaceuticals was estimated to be worth US$ 5400 million and is forecast to reach approximately US$ 8559 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis and treatment. Compounds or biological agents labeled with radionuclides used for medical diagnosis or treatment in the body.
Diagnostic radiopharmaceuticals are radioactive isotopes bound to biological molecules that can locate specific organs, tissues or cells in the human body. These radiopharmaceuticals can be used to diagnose diseases.
In vivo radiopharmaceuticals can be divided into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals, and the main diseases targeted include thyroid diseases, tumors, rheumatoid arthritis, bone metastasis, liver cancer, etc.
The diagnostic radiopharmaceuticals market is primarily driven by the rising incidence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, which require advanced imaging techniques for accurate diagnosis. The increasing use of PET and SPECT scans in healthcare systems worldwide has significantly boosted demand for diagnostic radiopharmaceuticals. Furthermore, innovations in molecular imaging, along with a growing focus on early detection and personalized medicine, are expanding the role of diagnostic radiopharmaceuticals in improving patient outcomes.
One of the key challenges facing the diagnostic radiopharmaceuticals market is the short half-life of many radiopharmaceutical compounds, which creates logistical difficulties in production, transportation, and storage. This limitation often requires proximity to specialized manufacturing facilities. Additionally, the market is constrained by regulatory barriers and the high costs associated with development and approval. Another challenge is the shortage of trained professionals in nuclear medicine, which limits the full utilization of diagnostic radiopharmaceuticals, particularly in emerging economies.
North America is the world's major consumer region, with sales accounting for 40% of the global total in 2023. Europe is also a major consumer region, accounting for 25% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals.
The Diagnostic Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Eli Lilly
China Isotope & Radiation
Dongcheng
Segment by Type
Technetium 99
Fluorine 18
Other
Segment by Application
Oncology
Cardiology
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Diagnostic Radiopharmaceuticals in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diagnostic Radiopharmaceuticals sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Diagnostic Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Market by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Diagnostic Radiopharmaceuticals Revenue 2020-2031
2.1.2 Global Diagnostic Radiopharmaceuticals Sales 2020-2031
2.2 Diagnostic Radiopharmaceuticals Market Size by Region: 2024 Versus 2031
2.3 Diagnostic Radiopharmaceuticals Sales by Region (2020-2031)
2.3.1 Global Diagnostic Radiopharmaceuticals Sales by Region: 2020-2025
2.3.2 Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2026-2031)
2.3.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2031)
2.4 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2020-2025
2.4.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2026-2031)
2.4.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2020-2031)
3.1.1.1 Global Diagnostic Radiopharmaceuticals Sales Volume by Type (2020-2031)
3.1.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2031)
3.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2020-2031)
3.1.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Type (2020-2031)
3.1.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2020-2031)
3.1.3 Diagnostic Radiopharmaceuticals Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2020-2031)
3.2.1.1 Global Diagnostic Radiopharmaceuticals Sales Volume by Application (2020-2031)
3.2.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2031)
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2020-2031)
3.2.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Application (2020-2031)
3.2.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2020-2031)
3.2.3 Diagnostic Radiopharmaceuticals Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Technetium 99 of Diagnostic Radiopharmaceuticals Revenue Market Share by Application
3.3.2 Fluorine 18 of Diagnostic Radiopharmaceuticals Revenue Market Share by Application
3.3.3 Other of Diagnostic Radiopharmaceuticals Revenue Market Share by Application
4 Global Diagnostic Radiopharmaceuticals by Manufacturers
4.1 Global Top Diagnostic Radiopharmaceuticals Manufacturers by Sales (2020-2025)
4.1.1 Global Diagnostic Radiopharmaceuticals Sales by Manufacturer (2020-2025)
4.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Diagnostic Radiopharmaceuticals Manufacturers by Revenue (2020-2025)
4.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturer (2020-2025)
4.2.2 Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturer (2020-2025)
4.3 Global Diagnostic Radiopharmaceuticals Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Diagnostic Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
4.4.2 Global Diagnostic Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Diagnostic Radiopharmaceuticals Manufacturing Base Distribution, Product Type
4.5.1 Diagnostic Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Diagnostic Radiopharmaceuticals Market
4.5.3 Manufacturers Diagnostic Radiopharmaceuticals Product Type and Application
4.5.4 Technetium 99 Market Sales of Diagnostic Radiopharmaceuticals by Manufacturer
4.5.5 Fluorine 18 Market Sales of Diagnostic Radiopharmaceuticals by Manufacturer
4.5.6 Other Market Sales of Diagnostic Radiopharmaceuticals by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Cardinal Health
5.1.1 Cardinal Health Company Information
5.1.2 Cardinal Health Description, Business Overview
5.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Products Offered
5.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Cardinal Health Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.1.6 Cardinal Health Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.1.7 Cardinal Health Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.1.8 Cardinal Health Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Company Information
5.2.2 GE Healthcare Description, Business Overview
5.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Products Offered
5.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GE Healthcare Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.2.6 GE Healthcare Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.2.7 GE Healthcare Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.2.8 GE Healthcare Recent Developments
5.3 Jubilant Pharma
5.3.1 Jubilant Pharma Company Information
5.3.2 Jubilant Pharma Description, Business Overview
5.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Products Offered
5.3.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.3.6 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.3.7 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.3.8 Jubilant Pharma Recent Developments
5.4 Novartis
5.4.1 Novartis Company Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Diagnostic Radiopharmaceuticals Products Offered
5.4.4 Novartis Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.4.6 Novartis Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.4.7 Novartis Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 Curium Pharma
5.5.1 Curium Pharma Company Information
5.5.2 Curium Pharma Description, Business Overview
5.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Products Offered
5.5.4 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Curium Pharma Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.5.6 Curium Pharma Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.5.7 Curium Pharma Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.5.8 Curium Pharma Recent Developments
5.6 SIEMENS
5.6.1 SIEMENS Company Information
5.6.2 SIEMENS Description, Business Overview
5.6.3 SIEMENS Diagnostic Radiopharmaceuticals Products Offered
5.6.4 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.6.5 SIEMENS Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.6.6 SIEMENS Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.6.7 SIEMENS Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.6.8 SIEMENS Recent Developments
5.7 Lantheus
5.7.1 Lantheus Company Information
5.7.2 Lantheus Description, Business Overview
5.7.3 Lantheus Diagnostic Radiopharmaceuticals Products Offered
5.7.4 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Lantheus Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.7.6 Lantheus Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.7.7 Lantheus Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.7.8 Lantheus Recent Developments
5.8 Bracco Imaging
5.8.1 Bracco Imaging Company Information
5.8.2 Bracco Imaging Description, Business Overview
5.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Products Offered
5.8.4 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Bracco Imaging Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.8.6 Bracco Imaging Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.8.7 Bracco Imaging Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.8.8 Bracco Imaging Recent Developments
5.9 Eli Lilly
5.9.1 Eli Lilly Company Information
5.9.2 Eli Lilly Description, Business Overview
5.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Products Offered
5.9.4 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Eli Lilly Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.9.6 Eli Lilly Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.9.7 Eli Lilly Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.9.8 Eli Lilly Recent Developments
5.10 China Isotope & Radiation
5.10.1 China Isotope & Radiation Company Information
5.10.2 China Isotope & Radiation Description, Business Overview
5.10.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Products Offered
5.10.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.10.5 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.10.6 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.10.7 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.10.8 China Isotope & Radiation Recent Developments
5.11 Dongcheng
5.11.1 Dongcheng Company Information
5.11.2 Dongcheng Description, Business Overview
5.11.3 Dongcheng Diagnostic Radiopharmaceuticals Products Offered
5.11.4 Dongcheng Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Dongcheng Diagnostic Radiopharmaceuticals Sales by Product in 2024
5.11.6 Dongcheng Diagnostic Radiopharmaceuticals Sales by Application in 2024
5.11.7 Dongcheng Diagnostic Radiopharmaceuticals Sales by Geographic Area in 2024
5.11.8 Dongcheng Recent Developments
6 North America
6.1 North America Diagnostic Radiopharmaceuticals Market Size YoY Growth 2020-2031
6.2 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
6.2.1 North America Diagnostic Radiopharmaceuticals Sales by Country (2020-2031)
6.2.2 North America Diagnostic Radiopharmaceuticals Revenue by Country (2020-2031)
6.3 North America Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
6.4 North America Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Diagnostic Radiopharmaceuticals Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Region
7.2.1 Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Region (2020-2031)
7.2.2 Asia-Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2020-2031)
7.3 Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
7.4 Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
8 Europe
8.1 Europe Diagnostic Radiopharmaceuticals Market Size YoY Growth 2020-2031
8.2 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
8.2.1 Europe Diagnostic Radiopharmaceuticals Sales by Country (2020-2031)
8.2.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2020-2031)
8.3 Europe Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
8.4 Europe Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Diagnostic Radiopharmaceuticals Market Size YoY Growth 2020-2031
9.2 Latin America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Latin America Diagnostic Radiopharmaceuticals Sales by Country (2020-2031)
9.2.2 Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2020-2031)
9.3 Latin America Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
9.4 Latin America Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Diagnostic Radiopharmaceuticals Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2020-2031)
10.2.2 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2020-2031)
10.3 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
10.4 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Diagnostic Radiopharmaceuticals Supply Chain Analysis
11.2 Diagnostic Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
11.3 Diagnostic Radiopharmaceuticals Clients Analysis
11.4 Diagnostic Radiopharmaceuticals Sales Channel and Sales Model Analysis
11.4.1 Diagnostic Radiopharmaceuticals Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Diagnostic Radiopharmaceuticals Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Diagnostic Radiopharmaceuticals Distributors
12 Diagnostic Radiopharmaceuticals Market Dynamics
12.1 Diagnostic Radiopharmaceuticals Industry Trends
12.2 Diagnostic Radiopharmaceuticals Market Drivers
12.3 Diagnostic Radiopharmaceuticals Market Challenges
12.4 Diagnostic Radiopharmaceuticals Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Diagnostic Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Diagnostic Radiopharmaceuticals Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Diagnostic Radiopharmaceuticals Sales by Region (2020-2025) & (K Dose)
Table 5. Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2026-2031) & (K Dose)
Table 6. Global Diagnostic Radiopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Diagnostic Radiopharmaceuticals Sales Volume by Type (2020-2025) & (K Dose)
Table 9. Global Diagnostic Radiopharmaceuticals Sales Volume by Type (2026-2031) & (K Dose)
Table 10. Global Diagnostic Radiopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Diagnostic Radiopharmaceuticals Sales Volume by Application (2020-2025) & (K Dose)
Table 13. Global Diagnostic Radiopharmaceuticals Sales Volume by Application (2026-2031) & (K Dose)
Table 14. Global Diagnostic Radiopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Diagnostic Radiopharmaceuticals Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Diagnostic Radiopharmaceuticals Sales by Manufacturer (2020-2025) & (K Dose)
Table 17. Global Diagnostic Radiopharmaceuticals Sales Share by Manufacturer (2020-2025)
Table 18. Diagnostic Radiopharmaceuticals Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Diagnostic Radiopharmaceuticals Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Diagnostic Radiopharmaceuticals Price (2020-2025) & (US$/Dose)
Table 21. Ranking of Global Top Diagnostic Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Diagnostic Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2024)
Table 24. Diagnostic Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Diagnostic Radiopharmaceuticals Market
Table 26. Manufacturers Diagnostic Radiopharmaceuticals Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Cardinal Health Company Information
Table 29. Cardinal Health Description and Business Overview
Table 30. Cardinal Health Diagnostic Radiopharmaceuticals Product
Table 31. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 32. Cardinal Health Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 33. Cardinal Health Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 34. Cardinal Health Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 35. Cardinal Health Recent Developments
Table 36. GE Healthcare Company Information
Table 37. GE Healthcare Description and Business Overview
Table 38. GE Healthcare Diagnostic Radiopharmaceuticals Product
Table 39. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 40. GE Healthcare Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 41. GE Healthcare Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 42. GE Healthcare Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 43. GE Healthcare Recent Developments
Table 44. Jubilant Pharma Company Information
Table 45. Jubilant Pharma Description and Business Overview
Table 46. Jubilant Pharma Diagnostic Radiopharmaceuticals Product
Table 47. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 48. Jubilant Pharma Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 49. Jubilant Pharma Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 50. Jubilant Pharma Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 51. Jubilant Pharma Recent Developments
Table 52. Novartis Company Information
Table 53. Novartis Description and Business Overview
Table 54. Novartis Diagnostic Radiopharmaceuticals Product
Table 55. Novartis Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 56. Novartis Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 57. Novartis Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 58. Novartis Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 59. Novartis Recent Developments
Table 60. Curium Pharma Company Information
Table 61. Curium Pharma Description and Business Overview
Table 62. Curium Pharma Diagnostic Radiopharmaceuticals Product
Table 63. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 64. Curium Pharma Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 65. Curium Pharma Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 66. Curium Pharma Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 67. Curium Pharma Recent Developments
Table 68. SIEMENS Company Information
Table 69. SIEMENS Description and Business Overview
Table 70. SIEMENS Diagnostic Radiopharmaceuticals Product
Table 71. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 72. SIEMENS Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 73. SIEMENS Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 74. SIEMENS Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 75. SIEMENS Recent Developments
Table 76. Lantheus Company Information
Table 77. Lantheus Description and Business Overview
Table 78. Lantheus Diagnostic Radiopharmaceuticals Product
Table 79. Lantheus Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 80. Lantheus Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 81. Lantheus Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 82. Lantheus Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 83. Lantheus Recent Developments
Table 84. Bracco Imaging Company Information
Table 85. Bracco Imaging Description and Business Overview
Table 86. Bracco Imaging Diagnostic Radiopharmaceuticals Product
Table 87. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Bracco Imaging Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 89. Bracco Imaging Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 90. Bracco Imaging Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 91. Bracco Imaging Recent Developments
Table 92. Eli Lilly Company Information
Table 93. Eli Lilly Description and Business Overview
Table 94. Eli Lilly Diagnostic Radiopharmaceuticals Product
Table 95. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 96. Eli Lilly Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 97. Eli Lilly Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 98. Eli Lilly Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 99. Eli Lilly Recent Developments
Table 100. China Isotope & Radiation Company Information
Table 101. China Isotope & Radiation Description and Business Overview
Table 102. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product
Table 103. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 104. China Isotope & Radiation Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 105. China Isotope & Radiation Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 106. China Isotope & Radiation Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 107. China Isotope & Radiation Recent Developments
Table 108. Dongcheng Company Information
Table 109. Dongcheng Description and Business Overview
Table 110. Dongcheng Diagnostic Radiopharmaceuticals Product
Table 111. Dongcheng Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 112. Dongcheng Sales Proportion of Diagnostic Radiopharmaceuticals by Product in 2024
Table 113. Dongcheng Sales Proportion of Diagnostic Radiopharmaceuticals by Application in 2024
Table 114. Dongcheng Sales Proportion of Diagnostic Radiopharmaceuticals by Geographic Area in 2024
Table 115. Dongcheng Recent Developments
Table 116. North America Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
Table 117. North America Diagnostic Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
Table 118. North America Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 119. North America Diagnostic Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 120. North America Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 121. North America Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 122. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Region (2020-2025) & (K Dose)
Table 123. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Region (2026-2031) & (K Dose)
Table 124. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
Table 125. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
Table 126. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 127. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 128. Europe Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
Table 129. Europe Diagnostic Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
Table 130. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 131. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 133. Europe Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 134. Latin America Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
Table 135. Latin America Diagnostic Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
Table 136. Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 137. Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 138. Latin America Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 139. Latin America Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 140. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
Table 141. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
Table 142. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
Table 143. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
Table 144. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 145. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 146. Diagnostic Radiopharmaceuticals Key Raw Materials, Industry Status and Trend
Table 147. Diagnostic Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
Table 148. Diagnostic Radiopharmaceuticals Clients Status and Trend
Table 149. Diagnostic Radiopharmaceuticals Typical Clients
Table 150. Diagnostic Radiopharmaceuticals Distributors
Table 151. Diagnostic Radiopharmaceuticals Market Trends
Table 152. Diagnostic Radiopharmaceuticals Market Drivers
Table 153. Diagnostic Radiopharmaceuticals Market Challenges
Table 154. Diagnostic Radiopharmaceuticals Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals Product Picture
Figure 2. Global Diagnostic Radiopharmaceuticals Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2024 & 2031
Figure 4. Technetium 99 Product Picture
Figure 5. Fluorine 18 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Diagnostic Radiopharmaceuticals Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2024 & 2031
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 13. Global Diagnostic Radiopharmaceuticals Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Diagnostic Radiopharmaceuticals Market Size 2020-2031 (US$ Million)
Figure 15. Global Diagnostic Radiopharmaceuticals Sales 2020-2031 (K Dose)
Figure 16. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2031)
Figure 18. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Diagnostic Radiopharmaceuticals Average Selling Price (ASP) by Type (2020-2025) & (US$/Dose)
Figure 21. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Diagnostic Radiopharmaceuticals Average Selling Price (ASP) by Application (2020-2025) & (US$/Dose)
Figure 24. Technetium 99 of Diagnostic Radiopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 25. Fluorine 18 of Diagnostic Radiopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 26. Other of Diagnostic Radiopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Diagnostic Radiopharmaceuticals Sales Share by Manufacturer in 2024
Figure 28. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. Technetium 99 Market Sales Proportion by Manufacturer in 2024
Figure 30. Fluorine 18 Market Sales Proportion by Manufacturer in 2024
Figure 31. Other Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Diagnostic Radiopharmaceuticals Revenue 2020-2031 (US$ Million)
Figure 33. North America Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 34. North America Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 40. Europe Diagnostic Radiopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2020-2031)
Figure 42. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 43. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 44. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 45. Latin America Diagnostic Radiopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2020-2031)
Figure 47. Latin America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 49. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 55. Diagnostic Radiopharmaceuticals Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Diagnostic Radiopharmaceuticals Raw Materials by Region in 2024
Figure 57. Diagnostic Radiopharmaceuticals Distribution Channels
Figure 58. Global Diagnostic Radiopharmaceuticals Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Diagnostic Radiopharmaceuticals Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
